Home
Iran
Politics
Tourism
Economy
Culture
Defense
Parliament
Science
Accidents
Health
World
West Asia
Asia Pacific
Europe
America
Africa
Organizations
Exclusive
Interview
Commentary
Report
News
Multimedia
Infographic
Picture
Video
Podcast
Sport
Iran Sports
World Sports
Watch Live
IP Direct
Schedule
About IP
Latest
IPORC
More
Health & Nutrition
Sci & Tech
IPORC
Watch Live
IP Direct
Tags
Schedule
December 15, 2024
Home
Iran
Politics
Tourism
Economy
Culture
Defense
Parliament
Science
Health
Accidents
World
West Asia
Asia Pacific
Europe
America
Africa
Organizations
Exclusive
Interview
Commentary
Report
News
Multimedia
Infographic
Picture
Video
Podcast
Sport
Iran Sports
World Sports
More
Health & Nutrition
Sci & Tech
About IP
Latest
December 15, 2024
Languages
English
العربية
فارسی
Français
Languages
English
العربية
فارسی
Français
Pfizer
Search
World Newspapers: Ages 12-17 approved for Pfizer booster
Thursday, 06 January 2022 20:11
The US Centers for Disease Control and Prevention on Wednesday endorsed the emergency use of Pfizer's booster shots for children ages 12 to 17, expanding protection to adolescents and teens as students return to classes and the highly contagious Omicron variant surges across the country.216
World Newspapers: Vaccine boosters to be authorised for ages 12 to 15
Friday, 31 December 2021 19:22
The US Food and Drug Administration is planning to broaden eligibility for coronavirus vaccine booster shots on Monday, allowing 12 to 15 year-old people to receive third doses of Pfizer-BioNTech’s vaccine, according to people familiar with the agency’s deliberations.
Pfizer COVID pill gets US authorization
Thursday, 23 December 2021 08:04
US authorises Pfizer oral COVID-19 treatment, first for at-home use
Pfizer's antiviral pill slashes risk of severe COVID-19 by 89%
Saturday, 06 November 2021 08:03
Pfizer Inc's (PFE.N) experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of severe disease, the company said on Friday.
Pfizer vaccine effectiveness drops after 6 months
Tuesday, 05 October 2021 08:12
The effectiveness of the Pfizer Inc (PFE.N)/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that US health agencies considered when deciding on the need for booster shots.
World Newspapers: US to request COVID booster shots for more people
Saturday, 25 September 2021 20:58
The head of the Centers for Disease Control and Prevention in the US overruled an advisory panel Friday by approving the distribution of Pfizer and BioNTech's COVID-19 booster shots to a wide array of workers across the country.
World Newspapers: Pfizer says shot safely benefits children 5 to 11
Tuesday, 21 September 2021 21:00
The Pfizer-BioNTech coronavirus vaccine has been shown to be safe and highly effective in children ages 5 to 11, the companies announced early Monday. The news sets the stage for authorization of the vaccine for younger children, possibly before the end of October. 214
Pfizer COVID-19 shot for kids age 5-11 could be authorized in October: Sources
Saturday, 11 September 2021 08:03
Top US health officials believe that Pfizer Inc's (PFE.N) COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday. 207/224
Iran negotiates with Europe over Pfizer, Moderna vaccines' import
Sunday, 22 August 2021 10:58
Tehran (IP): The spokesman of the National Task Force for Combating Coronavirus says Iran has entered into negotiations with one or two European countries to get the Pfizer and Moderna vaccines, which will definitely be imported if things go well.
World Newspapers: US youths 12 to 15 now eligible for Pfizer shot
Thursday, 13 May 2021 19:35
The US Food and Drug Administration approved Pfizer and BioN Tech’s request to allow their COVID-19 vaccine to be given to kids ages 12 to 15 on an emergency use basis, allowing states to get middle school students vaccinated before the fall.
<<
<
1
2
3
>
>>